Cytovene-IV is a deoxynucleoside analogue cytomegalovirus (CMV) DNA polymerase inhibitor. Cytovene-IV, a deoxynucleoside analogue cytomegalovirus (CMV) DNA polymerase inhibitor, is indicated to treat ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc. (Nasdaq: MCRB) today announced confirmatory results from ECOSPOR IV, an open-label study for SER-109, an investigational oral microbiome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback